Capecitabine (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Capecitabine drug offered from Mylan Institutional Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | capecitabine |
| SUBSTANCE NAME: | CAPECITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-01-21 |
| END MARKETING DATE: | 0000-00-00 |
Capecitabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Capecitabine from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2014-01-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51079-510_3aea9a4b-1a64-3edd-e054-00144ff8d46c |
| PRODUCT NDC: | 51079-510 |
| APPLICATION NUMBER: | ANDA090943 |
Other CAPECITABINE Pharmaceutical Manufacturers / Labelers:
